SEARCH RESULTS FOR: "Tag: ESPR"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(3)
2017(3)
2015(7)
CATEGORIES
Analyst Update(2)
Analyst Upgrades(1)
Buzz Stocks(3)
Ezines(1)
General(2)
Midday Market Check(1)
Opening View(1)
Stocks On the Move(5)
Technical Analysis(1)

5/29/2019 12:56 PM
This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...
5/6/2019 9:55 AM
Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...
5/2/2018 3:22 PM
The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...
3/27/2018 2:03 PM
The Dow is holding higher this afternoon thanks to a strong move from GE stock. Three other names making notable moves today are drug stocks Esperion Therapeutics Inc (NASDAQ:ESPR), Arrowhead Pharm...
3/7/2018 10:12 AM
Drugmakers Aptose Biosciences Inc (NASDAQ:APTO) and Esperion Therapeutics Inc (NASDAQ:ESPR) are both making headlines this morning, but for different reasons. We'll dig into APTO and ESPR stocks b...
 
Special Offers from Schaeffer's Trading Partners